RAIN
Price:
$1.21
Market Cap:
$44.01M
Rain Therapeutics Inc., a clinical-stage precision oncology company, engages in developing therapies that target oncogenic drivers in the United States. Its lead product candidate is milademetan, a small molecule oral inhibitor of mouse double minute 2, which is oncogenic in various cancers. The company is also developing milademetan which is in Phase 3 clinical trial for liposarcoma, Phase II clinical trial for solid tumors, and Phase II clinical trial for intimal sarcoma, as well as RAD52 which is in preclinical trials for tumors, including breast, ovarian, pancreatic, prostate, and other cancers. Rain Therapeutics Inc. was incorporated in 2017 and is headquartered in Newark, California.[Read more]
Industry
Biotechnology
IPO Date
2021-04-23
Stock Exchange
NASDAQ
Ticker
RAIN
According to Rain Therapeutics Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.16M. This represents a change of -93.89% compared to the average of 117.16M of the last 4 quarters.
The mean historical Enterprise Value of Rain Therapeutics Inc. over the last ten years is 165.91M. The current 7.16M Enterprise Value has changed 331.46% with respect to the historical average. Over the past ten years (40 quarters), RAIN's Enterprise Value was at its highest in in the September 2021 quarter at 383.13M. The Enterprise Value was at its lowest in in the September 2023 quarter at -5507446.73.
Average
165.91M
Median
164.05M
Minimum
109.97M
Maximum
225.58M
Discovering the peaks and valleys of Rain Therapeutics Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 105.12%
Maximum Annual Enterprise Value = 225.58M
Minimum Annual Increase = -33.71%
Minimum Annual Enterprise Value = 109.97M
Year | Enterprise Value | Change |
---|---|---|
2022 | 162.21M | -28.09% |
2021 | 225.58M | 105.12% |
2020 | 109.97M | -33.71% |
The current Enterprise Value of Rain Therapeutics Inc. (RAIN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
165.92M
5-year avg
165.91M
10-year avg
165.91M
Rain Therapeutics Inc.’s Enterprise Value is greater than AVROBIO, Inc. (-85302404.00), greater than CohBar, Inc. (-4403139.00), less than Ocean Biomedical, Inc. (35.80M), greater than Enveric Biosciences, Inc. (549.48K), less than Elevation Oncology, Inc. (26.87M), greater than Hepion Pharmaceuticals, Inc. (5.11M), greater than Zura Bio Limited (-6704987.00), greater than eFFECTOR Therapeutics, Inc. (4.74M),
Company | Enterprise Value | Market cap |
---|---|---|
-85302404.00 | $5.24M | |
-4403139.00 | $1.53M | |
35.80M | $23.68M | |
549.48K | $3.66M | |
26.87M | $44.05M | |
5.11M | $4.38M | |
-6704987.00 | $181.52M | |
4.74M | $941.00 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rain Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Rain Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Rain Therapeutics Inc.'s Enterprise Value?
What is the highest Enterprise Value for Rain Therapeutics Inc. (RAIN)?
What is the 3-year average Enterprise Value for Rain Therapeutics Inc. (RAIN)?
What is the 5-year average Enterprise Value for Rain Therapeutics Inc. (RAIN)?
How does the current Enterprise Value for Rain Therapeutics Inc. (RAIN) compare to its historical average?